BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu IC, Jean MC, Lin CW, Chen WH, Perng DS, Lin CW, Chuang HY. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine. Medicine (Baltimore) 2016;95:e5023. [PMID: 27684874 DOI: 10.1097/MD.0000000000005023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Bhattacharya S, Gökdemir Ö, Bashar MA, Thiyagarajan A, Singh A. Is it the Right Time to Introduce the Hepatitis B Booster Vaccine in National Immunization Schedule? An Analysis from the Available Evidence. Indian J Community Med 2021;46:4-6. [PMID: 34035566 DOI: 10.4103/ijcm.IJCM_439_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mahallawi W. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah. Ann Saudi Med 2018;38:413-9. [PMID: 30531175 DOI: 10.5144/0256-4947.2018.413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zhao YL, Han BH, Zhang XJ, Pan LL, Zhou HS, Gao Z, Hao ZY, Wu ZW, Ma TL, Wang F, Li Q, Bi SL, Ma JC. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infect Dis 2019;19:482. [PMID: 31146699 DOI: 10.1186/s12879-019-4134-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]